Distinguished Chair, honourable Members of the Executive Board,

I speak on behalf of the International Pharmaceutical Federation, representing over 5.5 million pharmacists, educators and pharmaceutical scientists worldwide.

FIP commends WHO and Member States for their continued commitment to protecting patients from fake medicines. We particularly welcome WHO’s 2025 Training Toolkit on Substandard and Falsified Medical Products, which aims to equip health professionals with skills needed to prevent, detect and respond to such products.

This initiative complements FIP’s longstanding work, including our curriculum for pharmacy students on fake medicines and our recently developed teaching modules on the risks of fake products online. Together, these tools build capacity for pharmacists to safeguard medicine quality.

As WHO advances its 2026–2027 priorities for the Mechanism, FIP looks forward to our continued collaboration.

Thank you.

Read our full statement here: https://www.fip.org/file/6474